Revolution Medicines, Inc. <RVMD.O>: Truist Securities raises target price to $239 from $231
RVMD•Related News
Revolution Medicines, Inc. <RVMD.O>: Oppenheimer raises target price to $260 from $230
RVMD•
Cushman & Wakefield survey shows 85% of APAC investors plan to raise living-sector allocation
CWK•
Nasdaq Trade Halt <WHLRP.O> Halt News Pending at 07:50 PM
WHLRP•
Global Markets: Asian stocks rise for third day as Nvidia beats
NVDA•
Lumentum President, Global Business Units Wupen Yuen disposes of 1,500 common shares for $1,281,517.5
LITE•